Workgroup Members

Chairperson: Kimberly A. Workowski, MD,  National Center for HIV, Viral Hepatitis, STD, and TB Prevention, CDC, and Emory University, Atlanta, Georgia.

Workgroup Members: Elizabeth Alderman, MD, The Children’s Hospital at Montefiore, The Pediatric Hospital for Albert Einstein College of Medicine, Bronx, New York; Lindley Barbee, MD,  University of Washington and Public Health Seattle and King County STD Clinic, Seattle,; Luis Barroso, MD, Wake Forest Baptist Health, Winston-Salem, North Carolina; Gale Burstein, MD,  Erie County Department of Health, Buffalo, New York; Virginia A. Caine, MD, Marion County Public Health Department, Indiana University, Indianapolis; Carla Chibwesha, MD,  University of North Carolina at Chapel Hill; Stephanie Cohen, MD,  San Francisco Department of Public Health,  California; Susan Cu-Uvin, MD, Brown University, Providence, Rhode Island; Jodie Dionne-Odom, MD, University of Alabama at Birmingham; Julia Dombrowski, MD,  Public Health – Seattle and King County, University of Washington, Seattle; Carolyn Gardella, MD Veterans Affairs Puget Sound University of Washington, Seattle; William M. Geisler, MD, University of Alabama at Birmingham; Khalil G. Ghanem, MD, PhD, Johns Hopkins University, Baltimore, Maryland; Matthew Golden, MD Seattle and King County STD/HIV Program University of Washington; Margaret R. Hammerschlag, MD, SUNY Downstate Medical Center, Brooklyn, New York; H. Hunter Handsfield, MD, University of Washington Center for AIDS and STD, Seattle; King K. Holmes, MD, PhD, University of Washington, Seattle, Washington; Edward W. Hook III, MD, University of Alabama at Birmingham; Katherine Hsu, MD Ratelle STD/HIV Prevention Training Center, Massachusetts Department of Public Health, Boston; Christine Johnston MD University of Washington, Seattle; Patricia Kissinger, PhD  Tulane University School of Public Health and Tropical Medicine, New Orleans, Louisiana; Jeffrey D. Klausner, MD,  University of California Los Angeles ; Lisa E. Manhart, PhD University of Washington, Seattle; Jeanne Marrazzo, MD, University of Alabama at Birmingham; David H. Martin, MD, Tulane University, Louisiana State University Health Sciences Center, New Orleans, Louisiana; Leslie Massad, MD, Washington University, St. Louis, Missouri; Kenneth H. Mayer, MD, Fenway Health, The Fenway Institute, Harvard Medical School, Beth Israel Deaconess Hospital, Boston, Massachusetts; Candice McNeil, MD,  Wake Forest Baptist Health, Alabama/North Carolina HIV/STD Prevention Training Center, Forsyth County Department of Public Health, Winston-Salem, North Carolina; Leandro Mena, MD, University of Mississippi Medical Center, Jackson; Caroline Mitchell, MD,  Vincent Center for Reproductive Biology, Boston, Massachusetts; Okeoma Mmeje, MD,  University of Michigan, Ann Arbor; Anna-Barbara Moscicki, MD, University of California Los Angeles, Los Angeles, California; Christina A. Muzny, MD,  University of Alabama at Birmingham; Natalie Neu, MD,  Columbia University, New York, New York; Paul Nyirjesy, MD, Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, Pennsylvania; Jeff Peipert, MD, PhD, Indiana University, Indianapolis; Rebecca Perkins, MD, Boston University, Boston; Susan Philip, MD San Francisco Department of Public Health, San Francisco; Asa Radix, MD, PhD Callen-Lorde Community Health Center, New York, New York; Anne Rompalo, MD, Johns Hopkins University, Baltimore, Maryland; Sarah Rudman, MD County of Santa Clara Public Health Department, San Jose, California; Pablo J. Sanchez, MD, The Ohio State University Nationwide Children’s Hospital, Columbus; George Sawaya, MD, University of San Francisco, San Francisco; Arlene Seña, MD, University of North Caroline at Chapel Hill and Durham County Department of Public Health, North Carolina; Jeanne Sheffield, MD, Johns Hopkins University, Baltimore, Maryland; Jack Sobel, MD, Wayne State University, Detroit, Michigan; David Soper, MD, Medical University of South Carolina, Charleston ; Anne Spaulding, MD, MPH, Emory University, Atlanta, Georgia; Bradley Stoner, MD, PhD, Washington University, St. Louis, Missouri; Stephanie Taylor, MD, Louisiana State University Crescent Care Sexual Health Center, New Orleans; Susan Tuddenham, MD Johns Hopkins University School of Medicine, Baltimore, Maryland; Karen Wendel, MD, Denver Public Health,  Colorado; Harold C. Wiesenfeld, MD, University of Pittsburgh, Pennsylvania; Jonathan Zenilman, MD, Johns Hopkins University, Baltimore, Maryland.

Moderators: Philip Chan, MD, Brown University, Providence, Rhode Island; Edward W. Hook III, MD, University of Alabama at Birmingham; Christine Johnston, MD University of Washington, Seattle; David H. Martin, MD, Tulane University, Louisiana State University Health Sciences Center, New Orleans, Louisiana; Jeanne Marrazzo, MD University of Alabama at Birmingham; Christina A. Muzny, MD University of Alabama at Birmingham; Ina Park, MD, University of California San Francisco; Hilary Reno, MD, PhD, Washington University, St. Louis, Missouri; Jonathan Zenilman, MD, Johns Hopkins University, Baltimore, Maryland

Rapporteurs: Philip Chan, MD, Brown University, Providence, Rhode Island; Hilary Reno, MD, PhD, Washington University, St. Louis, Missouri; Christine Johnston, MD,  University of Washington, Seattle; Christina A. Muzny, MD,  University of Alabama at Birmingham,; Ina Park, MD, ; University of California, San Francisco; Jonathan Zenilman, MD, Johns Hopkins University, Baltimore, Maryland

Liaison Participants: Jean Anderson, MD, CDC/HRSA Advisory Committee on HIV, Viral Hepatitis and STD Prevention/ Treatment, Johns Hopkins University, Baltimore, Maryland; Kevin Ault, MD,  American College of Obstetrics and Gynecologists, University of Kansas, Lawrences; Himani Bisht, PhD, U.S. Food and Drug Administration; J. Quentin Clemens, MD American Urological Association, University of Michigan, Ann Arbor; Gina Coleman, MD, Public Health Agency of Canada, Ottawa; Carolyn Deal, PhD, National Institute of Allergy and Infectious Diseases; Maeve B. Mello, PhD, Pan American Health Organization/World Health Organization Washington, D.C.; Diane Foley, MD, U.S. Department of Health and Human Services, Washington D.C.; Michael Ganio, PharmD, MS, American Society of Health-System Pharmacists, Bethesda, Maryland; Eric Garges, MD, MPH,  U.S. Department of Defense, Arlington, Virginia, Uniformed Services University, Bethesda, Maryland; Brent Gibson, MD, , National Commission on Correctional Health Care, Chicago, Illinois; William A. Glover II, PhD, Association of Public Health Laboratories, Silver Spring, Maryland; W. David Hardy, MD, HIV Medical Association, Johns Hopkins University, Baltimore, Maryland; David Harvey, National Coalition of STD Directors, Washington, D.C.; Letha Healey, MD, Health Resources and Services Administration (HIV/AIDS Bureau), Rockville, Maryland; Michael Huey, MD, American College Health Association, Silver Spring, Maryland, Emory University, Atlanta, Georgia; Gal Mayer, MD, GLMA: Health Professionals Advancing LGBTQ Equality, Washington, D.C.; Sumathi Nambiar, MD, , U.S. Food and Drug Administration, Silver Spring, Maryland; Seema Nayak, MD, National Institutes of Health, Rockville, Maryland; Lori Newman, MD, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland; Samantha Ritter, MPH, National Association of County and City Health Officials, Washington, D.C.; Elizabeth Ruebush, Association of State and Territorial Health Officials, Arlington, Virginia; Bisan Salhi, MD, PhD, American College of Emergency Physicians, Irving, Texas, Emory University, Atlanta, Georgia; Natasha Travis, MD, National Medical Association, Silver Spring, Maryland, Johns Hopkins University, Baltimore, Maryland; Maria Trent, MD, MPH, Society for Adolescent Health and Medicine, Chicago, Illinois, Johns Hopkins University, Baltimore, Maryland; Julie Vaishampayan, MD, , Infectious Disease Society of America, Arlington, Virginia; Barbara Van Der Pol, PhD, , American Sexually Transmitted Diseases Association, Research Triangle Park, North Carolina, University of Alabama at Birmingham, ,; Teodora Elvira Wi, MD, Department of Global HIV, Hepatitis and STI Programmes, World Health Organization, Geneva, Switzerland

CDC Consultants: Sevgi O. Aral, PhD; Laura H. Bachmann, MD; Kyle Bernstein, PhD; Gail Bolan, MD; John Brooks, MD; Philip Chan, MD, Brown University, Providence, Rhode Island; Aaron Harris, MD, MPH; Matthew Hogben, PhD; Sarah Kidd, MD; Kristen Kreisel, PhD; Lauri Markowitz, MD; Ina Park, MD University of California San Francisco; Laura Quilter, MD; Hilary Reno, MD, PhD, Washington University, St. Louis, Missouri; Sancta St. Cyr MD; Mona Saraiya, MD; Julie Schillinger, MD; Virginia Senkomago, PhD; Philip Spradling, MD; Phoebe Thorpe, MD; Mark Weng, MD

CDC, Division of Sexually Transmitted Disease Prevention Treatment Guidelines 2021 Project Coordinator: Kimberly A. Workowski, MD National Center for HIV, Viral Hepatitis, STD, and TB Prevention. CDC, and Emory University, Atlanta, Georgia.

CDC Support Staff: Alexandra Coor, MPH; Quinn Haaga; Amber Herald; Patricia Jackson; Brenda Kelly

Conflicts of Interest: Lindley Barbee, received research support from Hologic and SpeeDx and consults for Nabriva; Christine Johnston, research funding from Sanofi-Pasteur and royalties from UpToDate; Jeffrey Klausner, research supplies from Hologic, Cepheid and SpeeDx diagnostics, advisory fees from Shield Diagnostics, Click Diagnostics and SpeeDx Diagnostics, received research funding from AbbVie and Gilead Sciences; Lisa Manhart, research supplies, honoraria, and research contracts from Hologic Inc., consultant to diagnostic test manufacturers (SpeeDx, BioFire, Roche, and Click Diagnostics); Jeanne Marrazzo, expert advisory boards for BD, BioFire, and Gilead. Has research and grant support and supplies from Merck & Co. Inc and Toltec; David Martin, consultant to Hologic Inc during  the past year, which has recently gained FDA clearance for a Mycoplasma genitalium diagnostic test and markets diagnostic tests for gonorrhea, chlamydia and trichomonas; Kenneth Mayer, on the scientific advisory boards for Gilead Sciences and Merck & Co. Inc Pharmaceuticals, receives grant funds from Gilead Sciences; Leandro Mena, research funding through his institution from Atlas Genetics, Inc., Merck & Co. Inc, Becton Dickinson and Company, Hologic, Biolytical, Roche, received consulting honoraria from Roche Molecular, Merck & Co. Inc, Gilead Science, and ViiV Healthcare and from speaker bureaus for Gilead Science and ViiV Healthcare; Caroline Mitchell, served as a consultant for Lupin Pharmaceuticals and Scynexis Inc., and receives grant funding from Merck & Co. Inc; Christina A. Muzny, consultant and research support from Lupin Pharmaceuticals on an RCT of secnidazole versus placebo for treatment of trichomoniasis, speaker for Abbott Molecular, Cepheid, and Roche Diagnostics on topics related to STIs, consultant for Bio Fire Diagnostics; Paul Nyirjesy, research support from Mycovia Pharmaceuticals, Curatek Pharmaceuticals, Scynexis, Inc. and Hologic, consultant for Mycovia Pharmaceuticals, Hologic, Scynexis Inc., Daré Bioscience Inc., and BD;  Jeffery Pepest, advisory boards for Cooper Surgical and Bayer, provides research support to Merck & Co. Inc; Susan Philip, unpaid public health advisor to GlaxoSmithKline; Anne Rompalo, on the BioFire advisory board and has financial ties to UpToDate; Hilary Reno, site principle investigator on a project evaluating the prevalence of M. genitalium funded by Hologic. Funds are allocated via her institution; Arlene Seña, speaker’s bureau and scientific advisory board for M. genitalium at Hologic, works with the Gilead Focus grant for Hepatitis C testing and linkage to care, mentored Dr. Sancta St. Cyr at the University of North Carolina Division of Infectious Diseases before employment at  CDC; Anne Spaulding, has received consulting fees and/or honoraria (either directly or through third parties) in the past from: Gilead Sciences, Merck & Co. Inc., and AbbVie, had grants through her institution from Gilead Sciences and ViiV; Susan Tuddenham has been a consultant for Biofire and Roche Molecular Diagnostics and has received a speaker honorarium from Roche Molecular Diagnostics; Karen Wendel has stock ownership in Pfizer.